News
Successful combination: existing drugs boost cancer vaccine responsesInovio's universal avian flu vaccine generates protective antibody responses in phase 1Update on NewLink’s HyperAcute cancer immunotherapy productsGhana and Rwanda expand national immunization programsNews studies: Combining P...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2012-07-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Online Access: | https://www.tandfonline.com/doi/10.4161/hv.21443 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850054501074993152 |
|---|---|
| author | Eva M. Riedmann |
| author_facet | Eva M. Riedmann |
| author_sort | Eva M. Riedmann |
| collection | DOAJ |
| description | Successful combination: existing drugs boost cancer vaccine responsesInovio's universal avian flu vaccine generates protective antibody responses in phase 1Update on NewLink’s HyperAcute cancer immunotherapy productsGhana and Rwanda expand national immunization programsNews studies: Combining PROSTVAC with conventional cancer therapyPromising phase 1 data for the first "Cross-Kingdom“ vaccine Oral TB vaccine shows promise in phase 2 trial |
| format | Article |
| id | doaj-art-2f8bdd95e8874c20a155e2719ecbb213 |
| institution | DOAJ |
| issn | 2164-5515 2164-554X |
| language | English |
| publishDate | 2012-07-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj-art-2f8bdd95e8874c20a155e2719ecbb2132025-08-20T02:52:13ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2012-07-018784685010.4161/hv.21443NewsEva M. RiedmannSuccessful combination: existing drugs boost cancer vaccine responsesInovio's universal avian flu vaccine generates protective antibody responses in phase 1Update on NewLink’s HyperAcute cancer immunotherapy productsGhana and Rwanda expand national immunization programsNews studies: Combining PROSTVAC with conventional cancer therapyPromising phase 1 data for the first "Cross-Kingdom“ vaccine Oral TB vaccine shows promise in phase 2 trialhttps://www.tandfonline.com/doi/10.4161/hv.21443 |
| spellingShingle | Eva M. Riedmann News Human Vaccines & Immunotherapeutics |
| title | News |
| title_full | News |
| title_fullStr | News |
| title_full_unstemmed | News |
| title_short | News |
| title_sort | news |
| url | https://www.tandfonline.com/doi/10.4161/hv.21443 |
| work_keys_str_mv | AT evamriedmann news |